Purpose of this study was to determine the frequency of JAK2 V617F mutation in Philadelphia Chromosome positive (Ph +) CML patients in Pakistan. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.